(1888PressRelease)
February 09, 2009 - Biotrial announced today that it will be exhibiting at the 10th Annual Phase I Clinical Trials Conference in London.
Since 1989 Biotrial offers a wide range of services in clinical development: from Phase I, proof of concept, QT studies to central ECG laboratory, biostatistics, report writing, and many more.
“Biotrial's mission is to provide study sponsors with high-quality pharmacology services, adding value to their projects by working together and meeting all their needs throughout the development process,” said Jean-Marc Gandon, Biotrial CEO. “This is one of the reasons why we are delighted to be attending this conference, which is a great event for all phase I professionals and specialists. It is also an opportunity for us to meet with customers, new clients, and industry partners in one setting. Now, more than ever, early compound development is the key to the clinical trial process. And Biotrial, because of our experience, expertise, and high quality staff, is proud to be at the cuttingedge of it.
Exhibition visitors will be able to discover Biotrial’s latest developments and to meet with two of their key executives: Alain Patat, VP of Medical, Scientific & Quality Affairs, as well as Philippe L’ Hostis, Managing Director of the Central ECG and Imaging Laboratory.
Biotrial will be exhibiting at Booth #5.
About Biotrial
Founded in 1989 by Jean-Marc Gandon, PharmD (President & CEO), Biotrial is an independent and privately owned CRO.
With 150 beds and a staff of 250 in several subsidiaries in France and the UK, Biotrial runs over 80 studies per year, either in their own clinics in Paris and Rennes, or in cooperation with hospital specialists and general practitioners.
With a large range of services from Phase I studies, Clinical Trial Management Phase II-IV, Oncology, Data Management, Biostatistics, Central Labs (ECG, MRI), Medical Writing, Non-Clinical Pharmacology, QA & advice in Regulatory Affairs, Biotrial can manage every step of your development process.
For further information please contact Anne Peron at [+33] (0)2 99 599 191 or visit: www.biotrial.com.
###
